# A Study to Evaluate the Relative Bioavailability of Povetacicept Formulations and Bioequivalence of Povetacicept Presentations

> **NCT07010406** · PHASE1 · COMPLETED · sponsor: **Vertex Pharmaceuticals Incorporated** · enrollment: 136 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Povetacicept

## Key facts

- **NCT ID:** NCT07010406
- **Lead sponsor:** Vertex Pharmaceuticals Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-06
- **Primary completion:** 2025-08-19
- **Final completion:** 2025-08-19
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2025-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07010406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07010406, "A Study to Evaluate the Relative Bioavailability of Povetacicept Formulations and Bioequivalence of Povetacicept Presentations". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07010406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*